| Multiple Sclerosis |
1 |
1 |
| Monoclonal Antibody |
0 |
0.64 |
| Adverse Effects |
0 |
0.43 |
| Multiple Sclerosis Relapse |
0 |
0.43 |
| Immune Tolerance |
0 |
0.3 |
| Disease-Modifying Therapy |
0 |
0.21 |
| Multiple Sclerosis Treatment |
0 |
0.21 |
| Remission |
0 |
0.21 |
| Tobacco Use |
0 |
0.21 |
| Tolerance |
0 |
0.21 |
| Washington |
0 |
0.21 |
| COVID-19 |
0 |
0.15 |
| Patient Safety |
0 |
0.15 |
| Dentistry and Oral Health |
0 |
0.13 |
| Headache |
0 |
0.08 |
| Tobacco Cessation |
0 |
0.08 |